{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:22:30Z","timestamp":1740147750182,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s11739-020-02274-7","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T15:02:32Z","timestamp":1579014152000},"page":"13-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Percutaneous treatment of mitral regurgitation: looking for a final model"],"prefix":"10.1007","volume":"15","author":[{"given":"Marianna","family":"Adamo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6691-8568","authenticated-orcid":false,"given":"Marco","family":"Metra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,14]]},"reference":[{"key":"2274_CR1","doi-asserted-by":"crossref","unstructured":"Nickenig G, Estevez-Loureiro R, Franzen O, Tamburino C, Vanderheyden M, L\u00fcscher TF, Moat N, Price S, Dall\u2019Ara G, Winter R, Corti R, Grasso C, Snow TM, Jeger R, Blankenberg S, Settergren M, Tiroch K, Balzer J, Petronio AS, B\u00fcttner HJ, Ettori F, Sievert H, Fiorino MG, Claeys M, Ussia GP, Baumgartner H, Scandura S, Alamgir F, Keshavarzi F, Colombo A, Maisano F, Ebelt H, Aruta P, Lubos E, Plicht B, Schueler R, Pighi M, Di Mario C; Transcatheter Valve Treatment Sentinel Registry Investigators of the EURObservational Research Programme of the European Society of Cardiology (2014) Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011\u20132012 Pilot European Sentinel Registry. J Am Coll Cardiol 64:875\u2013884","DOI":"10.1016\/j.jacc.2014.06.1166"},{"key":"2274_CR2","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.jacc.2013.02.094","volume":"62","author":"F Maisano","year":"2013","unstructured":"Maisano F, Franzen O, Baldus S, Sch\u00e4fer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W (2013) Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 62:1052\u20131061","journal-title":"J Am Coll Cardiol"},{"key":"2274_CR3","doi-asserted-by":"crossref","unstructured":"Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Mu\u00f1oz D, Rosenhek R, Sj\u00f6gren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL; ESC Scientific Document Group (2017) 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38(36):2739\u20132791","DOI":"10.1093\/eurheartj\/ehx391"},{"key":"2274_CR4","doi-asserted-by":"crossref","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891\u2013975","DOI":"10.1002\/ejhf.592"},{"issue":"15","key":"2274_CR5","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","volume":"364","author":"Ted Feldman","year":"2011","unstructured":"Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV,Massaro JM, Mauri L; EVEREST II Investigators (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364:1395\u20131406","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"2274_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s11739-019-02140-1","volume":"14","author":"T Bini","year":"2019","unstructured":"Bini T, Agostini C, Stolcova M, Meucci F, Di Mario C (2019) One more option in heart failure: correction of mitral regurgitation with MitraClip\u00ae. Intern Emerg Med. 14(7):1033\u20131040","journal-title":"Intern Emerg Med."},{"issue":"24","key":"2274_CR7","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","volume":"379","author":"Jean-Fran\u00e7ois Obadia","year":"2018","unstructured":"Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, Lef\u00e8vre T, Piot C, Rouleau F, Carri\u00e9 D, Nejjari M, Ohlmann P, Leclercq F, Saint Etienne C, Teiger E, Leroux L, Karam N, Michel N, Gilard M, Donal E, Trochu JN, Cormier B, Armoiry X, Boutitie F, Maucort-Boulch D, Barnel C, Samson G, Guerin P, Vahanian A, Mewton N; MITRA-FR Investigators (2018) Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med 379(24):2297\u20132306","journal-title":"New England Journal of Medicine"},{"key":"2274_CR8","doi-asserted-by":"crossref","unstructured":"Iung B, Armoiry X, Vahanian A, Boutitie F, Mewton N, Trochu JN, Lef\u00e8vre T, Messika-Zeitoun D, Guerin P, Cormier B, Brochet E, Thibault H, Himbert D, Thivolet S, Leurent G, Bonnet G, Donal E, Piriou N, Piot C, Habib G, Rouleau F, Carri\u00e9 D, Nejjari M, Ohlmann P, Etienne CS, Leroux L, Gilard M, Samson G, Rioufol G, Maucort-Boulch D, Obadia JF; MITRA-FR Investigators (2019) Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2\u2009years. Eur J Heart Fail 21(12):1619\u20131627","DOI":"10.1002\/ejhf.1616"},{"issue":"24","key":"2274_CR9","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","volume":"379","author":"Gregg W. Stone","year":"2018","unstructured":"Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, Rajagopal V, Sarembock IJ, Brieke A, Marx SO, Cohen DJ, Weissman NJ, Mack MJ; COAPT Investigators (2018) Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med 379(24):2307\u20132318","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"2274_CR10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/ejhf.1491","volume":"21","author":"M Senni","year":"2019","unstructured":"Senni M, Adamo M, Metra M, Alfieri O, Vahanian A (2019) Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials? Eur J Heart Fail. 21(7):852\u2013861","journal-title":"Eur J Heart Fail."},{"issue":"3","key":"2274_CR11","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/ejhf.910","volume":"20","author":"NA Geis","year":"2018","unstructured":"Geis NA, Puls M, Lubos E, Zuern CS, Franke J, Schueler R, von Bardeleben RS, Boekstegers P, Ouarrak T, Zahn R, Ince H, Senges J, Katus HA, Bekeredjian R (2018) Safety and efficacy of MitraClip\u2122 therapy in patients with severely impaired left ventricular ejection fraction: results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail. 20(3):598\u2013608","journal-title":"Eur J Heart Fail."},{"issue":"3","key":"2274_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/ejhf.864","volume":"20","author":"E Tigges","year":"2018","unstructured":"Tigges E, Blankenberg S, von Bardeleben RS, Z\u00fcrn C, Bekeredjian R, Ouarrak T, Sievert H, Nickenig G, Boekstegers P, Senges J, Schillinger W, Lubos E (2018) Implication of pulmonary hypertension in patients undergoing MitraClip therapy: results from the German transcatheter mitral valve interventions (TRAMI) registry. Eur J Heart Fail 20(3):585\u2013594","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"2274_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ejhf.1289","volume":"21","author":"M Ke\u00dfler","year":"2019","unstructured":"Ke\u00dfler M, Seeger J, Muche R, W\u00f6hrle J, Rottbauer W, Markovic S (2019) Predictors of rehospitalization after percutaneous edge-to-edge mitral valve repair by MitraClip implantation. Eur J Heart Fail 21(2):182\u2013192","journal-title":"Eur J Heart Fail"},{"key":"2274_CR14","doi-asserted-by":"crossref","unstructured":"Capodanno D, Adamo M, Barbanti M, Giannini C, Laudisa ML, Cannata S, Curello S, Imm\u00e8 S, Maffeo D, Bedogni F, Petronio AS, Ettori F, Tamburino C, Grasso C; GRASP-IT Investigators (2015) Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair. Am Heart J 170:187\u2013195","DOI":"10.1016\/j.ahj.2015.04.010"},{"issue":"27","key":"2274_CR15","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1093\/eurheartj\/ehz222","volume":"40","author":"F Praz","year":"2019","unstructured":"Praz F, Grasso C, Taramasso M, Baumbach A, Piazza N, Tamburino C, Windecker S, Maisano F, Prendergast B (2019) Mitral regurgitation in heart failure: time for a rethink. Eur Heart J 40(27):2189\u20132193","journal-title":"Eur Heart J"},{"key":"2274_CR16","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jcmg.2018.11.006","volume":"12","author":"PA Grayburn","year":"2018","unstructured":"Grayburn PA, Sannino A, Packer M (2018) Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging 12:353\u2013362","journal-title":"JACC Cardiovasc Imaging"},{"key":"2274_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1469","author":"M Packer","year":"2019","unstructured":"Packer M (2019) Disproportionate functional mitral regurgitation: a new therapeutic target in patients with heart failure and a reduced ejection fraction. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.1469","journal-title":"Eur J Heart Fail"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-020-02274-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-020-02274-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-020-02274-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T21:45:06Z","timestamp":1610574306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-020-02274-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["2274"],"URL":"https:\/\/doi.org\/10.1007\/s11739-020-02274-7","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"type":"print","value":"1828-0447"},{"type":"electronic","value":"1970-9366"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"2 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M. Adamo has not competing interests. M. Metra received honoraria for speeches from Abbott and Edwards and is involved as\u00a0member of Committees for clinical trials or as advisory board member from Abbott, AMGEN, Astra-Zeneca, Fresenius, Novartis, Servier, Vifor.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}